GENEVA, Nov. 10 -- SANOFI (46 avenue de la Grande Armee75017 Paris) filed a patent application (PCT/EP2025/062011) for "CRYSTALLINE FORM OF A PYRIDAZINE NLRP3 INHIBITOR" on May 01, 2025. With publication no. WO/2025/229146, the details related to the patent application was published on Nov 06, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): MARGUET, Frank (c/o Sanofi Patent Department46 avenue de la Grande Armee75017 Paris), RONAN, Baptiste (c/o Sanofi Patent Department46 avenue de la Grande Armee75017 Paris)
Abstract: The present disclosure relates to a compound of formula (I) which is in ...